Biochemistry, Genetics and Molecular Biology
Genomics
100%
Epigenetics
44%
Evolution
43%
Somatic Mutation
42%
Gene Expression
35%
Genetics
31%
DNA Repair
26%
Genome Instability
25%
DNA Damage
25%
Mutagenesis
24%
Dynamics
24%
Cancer Cell
23%
Replication Timing
23%
BRCA1
23%
Gene Mutation
22%
DNA Methylation
20%
B Cell
20%
Transcriptomics
20%
Homologous Recombination
18%
Oncogene
17%
Carcinogenesis
17%
Pan-cancer
16%
Loss of Heterozygosity
15%
Coding Region
15%
Germ Cell
14%
Methylation
14%
Genome Evolution
14%
Somatic Cell
14%
Point Mutation
13%
BRCA2
13%
Cancer Genomics
12%
Clinical Trial
12%
Cellular Differentiation
11%
Caenorhabditis Elegans
11%
High Throughput Sequencing
11%
Mouse Model
11%
Mutation Rate
11%
DNA Synthesis
10%
Evolutionary Adaptation
10%
Prevalence
9%
Microbiome
9%
Transcriptome
9%
RNA Sequencing
9%
Phosphotransferase
9%
Kinase
9%
Whole Genome Sequencing
9%
MicroRNA
9%
Genetic Heterogeneity
9%
Tumor Progression
8%
Immunity
8%
Keyphrases
In Cancer
68%
Cancer Genome
53%
Mutational Signatures
39%
Tumor
29%
Histopathology Images
28%
Cancer Types
27%
Nuclei Segmentation
24%
Somatic mutation
24%
Tumor Heterogeneity
23%
Gene Expression
21%
Genetic Modification
20%
Cancer Cells
20%
DNA Methylation (DNAm)
20%
Breast Cancer Susceptibility Gene 1 (BRCA1)
19%
Non-genetic
17%
Somatic Copy number Alterations
17%
Clinical Outcomes
16%
Protein-coding Genes
15%
Mutational Landscape
15%
Tumor Cells
15%
Epigenetics
15%
Pancreatic Ductal Adenocarcinoma
15%
Multiple Cancer Types
14%
DNA Replication Timing
14%
Tissue Sampling
14%
Loss of Heterozygosity
13%
Somatic Cells
13%
Genomic Data
13%
MicroRNA
13%
Human Tissue
13%
Tumorigenesis
13%
Mutagenesis
12%
Homologous Recombination
12%
Functional Types
12%
Genome Sequencing
12%
Epigenetic Modification
11%
Deep nuclei
11%
Unsupervised Learning
11%
Nuclei Classification
11%
Deep Learning Methods
11%
Point Annotation
11%
Caenorhabditis Elegans
11%
Ovarian Cancer Patients
11%
Genetic Neighborhood
11%
Single nucleotide Variant
11%
Tumor Evolution
11%
Acute Myeloid Leukemia
11%
Leukemia Stem Cells
11%
Drug Regimen
11%
Rational Design
11%
